Skip to main content
. 2021 Sep 1;46(4):367–376. doi: 10.1007/s10484-021-09521-3

Table 3.

Outcomes split by Hypo/Normocapnic at baseline

Pre Post 2-Month follow-up 6-Month follow-up
M (SD) M (SD) Est. mean change (SE) d′ M (SD) Est. mean change (SE) d′ M (SD) Est. mean change (SE) d′
Hypocapnic (Pre ETCO2 < 36 mmHg, n = 21)
 CAPS-5 47.8 (5.8) 25.3 (10.5) 22.5 (2.2) 1.9 21.9 (19.1) 26.0 (4.3) 1.3 17.4 (12.1) 30.4 (2.8) 2.3
 ETCO2 32.4 (2.4) 36.3 (5.4) 3.9 (1.3) 0.7
 RR 15.0 (4.2) 13.6 (7.3) 1.4 (1.1) 0.2
Normocapnic (Pre ETCO ≥ 36 mmHg, n = 27)
 CAPS-5 51.1 (11.3) 37.1 (15.3) 14.1 (3.0) 0.7 31.2 (16.2) 19.9 (3.2) 1.0 32.2 (19.2) 18.9 (3.4) 0.8
 ETCO2 39.4 (2.5) 39.1 (4.9) 0.3 (0.9) 0.1
 RR 14.8 (3.8) 13.3 (6.5) 1.5 (1.1) 0.2

CAPS-5 Clinician Administered PTSD Scale, PDSS Panic Disorder and Severity Scale, CHRT-SR Concise Health Risk Tracking Self-Report, PHQ-9 Patient health Questionnaire 9-item depression scale, CGI-S Clinician Global Impression—Severity score, SF-363 36-item Short Form Health Survey question 3 (Role functioning/emotional), ETCO2 End-tidal carbon dioxide (mmHg), RR Respiration Rate (breaths per minute, bpm)